Close this search box.

Intel Capital invests $10 million in AI powered medical startup

Lumiata, an AI-powered predictive analytics company, has raised $10 million in a financing round led by Intel Capital. Lumiata supplies organisations in healthcare with AI powered risk management tools.
Lumiata is accelerating its deployment of medical artificial intelligence in order to improves risk and care management for payers, physicians and population health organizations embracing population health management to ultimately drive more personalized care.

All existing Lumiata investors, including Blue Cross Blue Shield Venture Partners, Sandbox Industries, and Khosla Ventures participated in this Series B Round.The latest round of funding brings the total amount of capital raised by Lumiata to $20 million.

More efficient risk management

 Healthcare’s rapidly evolving business models require more precise and efficient ways to manage risk, Lumiata says. Some 30 percent of healthcare providers are in risk-sharing agreements today, a figure that is expected to at least double by 2020. However, the inability to share and analyze claims and clinical data in real-time often makes it virtually impossible to effectively manage risk and generate quality outcomes. Lumiata believes its technology and approach to analytics, enable organizations to identify and manage risk with the precision, efficiency and transparency needed to deliver on value-based care. 

By  combining data science with medical science and literature, the Lumiata Medical Graph models human pathophysiology to yield the company’s main product, the Lumiata Risk Matrix. This Risk Matrix provides the current and evolving risk of each individual within a population through highly precise, time-based predictions coupled with medical reasoning.

Integrating old and new data streams

“By integrating new data streams, such as IoT, with traditional clinical data, Lumiata has the potential to bring a fresh approach to managing risk with healthcare analytics,” said Steve Agritelley, General Manager of the Health and Life Sciences Group at Intel Corporation, in a joint statement.

Lumiata is a predictive analytics company that leverages medical artificial intelligence to enable health organizations to manage risk and prioritize care.It was founded in 2013 and is based in Silicon Valley. Its team is comprised of clinicians, data scientists, and experts in care delivery.

Intel Capital is Intel’s strategic investment and M&A organization. It backs innovative startups worldwide targeting computing and smart devices, cloud, datacenter, security, the Internet of Things, wearable and robotic technologies and semiconductor manufacturing.


ICT&health World Conference 2024

Experience the future of healthcare at the ICT&health World Conference from May 14th to 16th, 2024!
Secure your ticket now and immerse yourself in groundbreaking technologies and innovative solutions.
Engage with fellow experts and explore the power of global collaborations.

Share this article!

Read also
Navigating Digital Maturity in Healthcare IT
Digital maturity vs. Reality. How to rethink the IT staff role in a hospital
Online health care icon application on smart phone
End-users of mobile health apps expect far more than a good design
Mayo Clinic started with its innovations for its ten million patients and demonstrated that its model worked, and that data could be ethically and responsibly used to drive innovations.
John Halamka: 'Create the Fear of Missing Out'
Balancing regulatory compliance with seamless adoption, healthcare navigates the integration of AI solutions.
A guide to implementing AI in healthcare amid the EU AI Act
Futurist Amy Webb claims that wearables will evolve into "connectables"
Digital health solutions empower patients to better manage their health and integrate care into their daily lives.
How to improve Digital Patient Engagement to streamline workflows
For people with diabetes, inaccurate blood glucose measurements can lead to errors in diabetes management, including taking the wrong dose of insulin, sulfonylureas, or other medications that can rapidly lower blood glucose.
Smartwatches measuring glucose level: Harmful but easy to buy fake innovations
How to introduce innovation and AI in healthcare organizations if there is no business model for prevention and quality – Our interview with Professor Ran Balicer, the Chief Innovation Officer at Clalit Health Services and founding Director of Clalit Research Institute.
I see no legitimate rationale for delaying the digital transformation in healthcare
Pioneering Cardiac Arrest Detection for Enhanced Survival.
CardioWatch Revolutionizes Cardiac Arrest Detection
Dr. Oscar Díaz-Cambronero, Head of Perioperative Medicine Department at La Fe Hospital, spearheads innovative telemonitoring initiatives revolutionizing patient care
Smartwatches Saving Lives Inside and Outside the Hospital
Follow us